Latest news with #LINAC
India.com
a day ago
- Business
- India.com
PLI Schemes See Actual Investment Of Rs 1.76 Lakh Crore, Create Over 12 Lakhs Jobs: Minister
New Delhi: The production-linked incentive (PLI) schemes have realised actual investment of Rs. 1.76 lakh crore till March 2025 across 14 sectors, which has resulted in incremental production/sales of over Rs. 16.5 lakh crore and employment generation of over 12 lakhs (direct and indirect), the Parliament was informed on Tuesday. To date, 806 applications have been approved under PLI schemes across 14 sectors. These schemes have incentivized domestic manufacturing, leading to increased production, job creation and a boost in exports, said Minister of State for Commerce and Industry, Jitin Prasada, in a written reply to the Lok Sabha. The pharmaceuticals sector has witnessed cumulative sales of Rs 2.66 lakh crore which includes exports of Rs 1.70 lakh crore achieved in the first three years of the scheme. The scheme has contributed to India becoming a net exporter of bulk drugs (Rs 2,280 crore) from net importer (-1,930 crore) as was the case in FY 2021-22. It has also resulted in significant reduction in gap between the domestic manufacturing capacity and demand of critical drugs. Under the PLI Scheme for medical devices, 21 projects have started manufacturing of 54 unique medical devices, which include high end devices such as Linear Accelerator (LINAC), MRI, CT-Scan, Heart Valve, Stent, Dialyzer Machine, C-Arm, Cath Lab, Mammograph, MRI Coils, etc, the minister informed the House. The production of mobiles in value terms has increased by around 146 per cent from Rs 2,13,773 crore in 2020-21 to Rs 5,25,000 crore in 2024-25 as per industry association and DGCIS. During the same period, exports of mobile phones in value terms has increased by around 775 per cent from Rs 22,870 crore in 2020-21 to Rs 2,00,000 crore in 2024-25, he added. 'Cumulative incentive amount of Rs 21,534 crore have been disbursed as on 24.06.2025 under PLI Scheme for 12 sectors, namely Large Scale Electronics Manufacturing (LSEM), IT Hardware, Bulk Drugs, Medical Devices, Pharmaceuticals, Telecom & Networking Products, Food Processing, White Goods, Drones & Drone Components, Specialty Steel, Textile products and Automobiles & Auto components, the minister highlighted.
Hans India
a day ago
- Business
- Hans India
PLI schemes see actual investment of Rs 1.76 lakh crore, create over 12 lakhs jobs: Minister
New Delhi: The production-linked incentive (PLI) schemes have realised actual investment of Rs. 1.76 lakh crore till March 2025 across 14 sectors, which has resulted in incremental production/sales of over Rs. 16.5 lakh crore and employment generation of over 12 lakhs (direct and indirect), the Parliament was informed on Tuesday. To date, 806 applications have been approved under PLI schemes across 14 sectors. These schemes have incentivized domestic manufacturing, leading to increased production, job creation and a boost in exports, said Minister of State for Commerce and Industry, Jitin Prasada, in a written reply to the Lok Sabha. The pharmaceuticals sector has witnessed cumulative sales of Rs 2.66 lakh crore which includes exports of Rs 1.70 lakh crore achieved in the first three years of the scheme. The scheme has contributed to India becoming a net exporter of bulk drugs (Rs 2,280 crore) from net importer (-1,930 crore) as was the case in FY 2021-22. It has also resulted in significant reduction in gap between the domestic manufacturing capacity and demand of critical drugs. Under the PLI Scheme for medical devices, 21 projects have started manufacturing of 54 unique medical devices, which include high end devices such as Linear Accelerator (LINAC), MRI, CT-Scan, Heart Valve, Stent, Dialyzer Machine, C-Arm, Cath Lab, Mammograph, MRI Coils, etc, the minister informed the House. The production of mobiles in value terms has increased by around 146 per cent from Rs 2,13,773 crore in 2020-21 to Rs 5,25,000 crore in 2024-25 as per industry association and DGCIS. During the same period, exports of mobile phones in value terms has increased by around 775 per cent from Rs 22,870 crore in 2020-21 to Rs 2,00,000 crore in 2024-25, he added. 'Cumulative incentive amount of Rs 21,534 crore have been disbursed as on 24.06.2025 under PLI Scheme for 12 sectors, namely Large Scale Electronics Manufacturing (LSEM), IT Hardware, Bulk Drugs, Medical Devices, Pharmaceuticals, Telecom & Networking Products, Food Processing, White Goods, Drones & Drone Components, Specialty Steel, Textile products and Automobiles & Auto components, the minister highlighted.
The Sun
2 days ago
- Business
- The Sun
UKM procurement irregularities found in RM66.64 million tenders
KUALA LUMPUR: Three out of seven procurement tenders by Universiti Kebangsaan Malaysia (UKM) worth RM66.64 million did not comply with stipulated procedures, according to the Auditor-General's Report (LKAN) 2/2025. The report, tabled in the Dewan Rakyat, highlighted serious irregularities in tender procurement and governance at the university. The UKM Tender Procurement Committee selected companies not recommended by the Technical Evaluation Committee, Financial Evaluation Committee, and Pre-Tender Committee. 'There were serious irregularities and weaknesses in the tender procurement process and procurement management governance at UKM,' the report stated. It further noted that the Pre-Tender Committee endorsed a company that had failed at the Tender Evaluation Committee level for a project involving the upgrading and replacement of 16 elevator units. The Vice-Chancellor, as Procurement Committee chairman, is responsible for ensuring proper governance under subsection 12(3) of the UKM Constitution. UKM also failed to appoint a Ministry of Finance (MoF) representative to the Procurement Committee, while the Ministry of Higher Education (KPT) representative did not attend meetings for the three tenders. Non-compliances included selecting a Linear Accelerator (LINAC) equipment supplier that did not meet integration specifications and advancing a technically disqualified company for food catering services to the final tender stage. A tender was awarded to a company listed for ailing projects in elevator replacement works, disregarding recommendations from three evaluation committees. This led to the contract being awarded to an incapable firm. The National Audit Department recommended revising UKM's procurement guidelines to align with Treasury Circulars and ensuring strict monitoring of LINAC supply and elevator works at Hospital Canselor Tuanku Muhriz (HCTM). 'Disciplinary action is also recommended against officers and committee members involved,' the report added. – Bernama
Barnama
2 days ago
- Business
- Barnama
UKM Failed To Follow Procedures In Three Procurement Tenders Worth RM66.64 Mln
KUALA LUMPUR, July 21 (Bernama) -- Three out of the seven procurement tenders by Universiti Kebangsaan Malaysia (UKM) totalling RM66.64 million were found to not comply with the stipulated procurement procedures, according to the Auditor-General's Report (LKAN) 2/2025 tabled in the Dewan Rakyat today. The report revealed that the UKM Tender Procurement Committee had selected companies that were not recommended by the Technical Evaluation Committee, Financial Evaluation Committee and Pre-Tender Committee. "There were serious irregularities and weaknesses in the tender procurement process and procurement management governance at UKM. The Tender Procurement Committee's decisions were made collectively by all members. "This includes the Pre-Tender Committee, which endorsed a company that had failed at the Tender Evaluation Committee level for the project involving the upgrading and replacement of 16 elevator units,' it added. The report also stated that the Vice-Chancellor, as the Procurement Committee chairman, is responsible for ensuring the university's operations and procurement governance are carried out properly, in line with subsection 12(3) of the UKM Constitution and the principle of duty of care. According to the report, UKM also failed to appoint a representative from the Ministry of Finance (MoF) as a member of the Procurement Committee, while the appointed representative from the Ministry of Higher Education (KPT) did not attend meetings regarding the three tenders. Among the non-compliances identified were the selection of a supplier for Linear Accelerator (LINAC) equipment that did not meet integration specifications with the existing system (ARIA), and taking a company that had failed at the technical level for food catering services to the final tender stage. The report also revealed that a tender was awarded to a company listed as an ailing project for elevator replacement works, in addition to disregarding the recommendations of three key evaluation committees. This decision resulted in the tender being awarded to a company not capable of fulfilling the contract within the stipulated period.
New Straits Times
07-07-2025
- Health
- New Straits Times
Health Ministry, IHH Healthcare ink MoU to expand free cancer treatment for 500 patients
PUTRAJAYA: The Health Ministry (MOH) and IHH Healthcare Malaysia signed their third Memorandum of Understanding (MoU) today, aimed at strengthening a strategic public-private partnership to improve access to advanced cancer treatment. Health Minister Datuk Seri Dr Dzulkefly Ahmad said the agreement will enable an additional 500 cancer patients to receive high-quality radiotherapy and radiosurgery at no cost, through services delivered by MOH oncologists and neurosurgeons via IHH's facilities. "This agreement also brings the total number of participating IHH facilities to eight hospitals, including the newly added Island Hospital in Penang, which are equipped with Gamma Knife and LINAC technologies allowing for precise, high-impact treatment, especially for tumours located in sensitive areas," he said after the MoU signing ceremony. The MoU was signed by MOH secretary-general Datuk Seri Suriani Ahmad and IHH Healthcare Malaysia chief executive officer Jean-François Naa. Dzulkefly said the collaboration, first established in 2022, has benefited 1,000 cancer patients nationwide so far. "This collaboration is a concrete step toward closing the access gap for underserved and lower-income groups. It also reflects Malaysia's broader commitment to Universal Health Coverage, where cancer care is not treated as a privilege but as a right. "We should never allow a patient's health outcome to be dictated by where they live or how much they earn," he said. Dzulkefly said from 2020 to 2024, the Malaysia National Cancer Registry recorded more than 165,000 new cancer cases, with breast, colorectal, lung, lymphoma and liver cancer being the most common. "Alarmingly, over 60 per cent of cases are detected at late stages, when treatment is more complex, costly, and less effective," he said. Meanwhile, according to a statement issued by MOH, the types of cancer treated under the MoU include brain tumours, brain metastases, head and neck cancers, as well as various other cancers such as lung, breast, colorectal and lymphoma. It said the MoU would serve as a catalyst in strengthening public-private partnerships, further supporting the ministry's efforts in combating cancer and expanding access to care and treatment for cancer patients in the country through continued cooperation between the MOH and IHH Healthcare Malaysia. "This initiative is also aligned with the National Strategic Plan for Cancer Control, which prioritises early detection, effective treatment, palliative care and broad system coordination to reduce the national cancer burden," the statement read. — BERNAMA
